|
Linde Gas Therapeutics Linde’s Healthcare operations embrace three sectors, namely Institutional (hospitals, doctors and rescue services), Respiratory Homecare (outpatients) and INO Therapeutics (intensive care). Our research concentrates on drug and device combinations for the respiratory system in the intensive care setting. Linde also supports the GEMI Fund, an organization devoted to stimulating research into medical applications for gas. (For detailed information on the GEMI Fund, see the section “Healthcare” in the "Society" chapter) |
![]() São Paulo, Brazil |
We are untiring in our efforts to offer users better and safer treatment methods based on medical gases. Our representatives are available to train and advise medical staff on site. We are also active in emerging nations such as those in South America, where we are a leading provider and generate more than ten percent of our Healthcare sales. We contribute to the further development of these countries by raising the standard of care and facilitating knowledge transfer.
In order to ensure maximum safety for patients, we operate a seamless quality control regime from the production facility to the place of application. We also document the safety and efficacy of our products in accordance with the applicable regulatory guidelines. In the event of new medical gas therapies, the pre-clinical and clinical documentation complies with the customary development directives for pharmaceutical products.

